Hypertrophy of (infrapatellar) fat pad

DOID EFO MESH PheWeb

M13_FATPADHYPERTROPHY

muscular disease: Acquired, familial, and congenital disorders of skeletal muscle and smooth muscle.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 M79.4

Hospital discharge: ICD-9 7293A

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 M79.4

Cause of death: ICD-9 7293A

Cause of death: ICD-8 $!$

239

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

239

Check minimum number of events None

239

Include endpoints None

239

M13_FATPADHYPERTROPHY

Extra metadata

Level in the ICD hierarchy 4

First used in FinnGen datafreeze DF2

Parent code in ICD-10 M79

Name in latin Hypertrophia corporis adiposi infrapatellaris

Similar endpoints

↥

List of similar endpoints to Hypertrophy of (infrapatellar) fat pad based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	232	151	81
Unadjusted prevalence (%)	0.08	0.09	0.06
Mean age at first event (years)	38.66	38.50	38.95

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: M13_FATPADHYPERTROPHY – Hypertrophy of (infrapatellar) fat pad
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Hypertrophy of (infrapatellar) fat pad
after Hypertrophy of (infrapatellar) fat pad

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Hypertrophy of (infrapatellar) fat pad

↥